» Articles » PMID: 39598735

Recent Applications of In Silico Approaches for Studying Receptor Mutations Associated with Human Pathologies

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2024 Nov 27
PMID 39598735
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, the advent of computational techniques to predict the potential activity of a drug interacting with a receptor or to predict the structure of unidentified proteins with aberrant characteristics has significantly impacted the field of drug design. We provide a comprehensive review of the current state of in silico approaches and software for investigating the effects of receptor mutations associated with human diseases, focusing on both frequent and rare mutations. The reported techniques include virtual screening, homology modeling, threading, docking, and molecular dynamics. This review clearly shows that it is common for successful studies to integrate different techniques in drug design, with docking and molecular dynamics being the most frequently used techniques. This trend reflects the current emphasis on developing novel therapies for diseases resulting from receptor mutations with the recently discovered AlphaFold algorithm as the driving force.

Citing Articles

Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches.

Hashem S, Dougha A, Tuffery P Molecules. 2025; 30(5).

PMID: 40076272 PMC: 11901715. DOI: 10.3390/molecules30051047.

References
1.
Miziak P, Baran M, Blaszczak E, Przybyszewska-Podstawka A, Kalafut J, Smok-Kalwat J . Estrogen Receptor Signaling in Breast Cancer. Cancers (Basel). 2023; 15(19). PMC: 10572081. DOI: 10.3390/cancers15194689. View

2.
Murzin A, Brenner S, Hubbard T, Chothia C . SCOP: a structural classification of proteins database for the investigation of sequences and structures. J Mol Biol. 1995; 247(4):536-40. DOI: 10.1006/jmbi.1995.0159. View

3.
Holm L . DALI and the persistence of protein shape. Protein Sci. 2019; 29(1):128-140. PMC: 6933842. DOI: 10.1002/pro.3749. View

4.
Bhargava R, Gerald W, Li A, Pan Q, Lal P, Ladanyi M . EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol. 2005; 18(8):1027-33. DOI: 10.1038/modpathol.3800438. View

5.
Kiyoi H, Kawashima N, Ishikawa Y . FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development. Cancer Sci. 2019; 111(2):312-322. PMC: 7004512. DOI: 10.1111/cas.14274. View